Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications ; volume:9 ; number:1 ; day:25 ; month:5 ; year:2011 ; pages:1-9 ; date:12.2011
BMC medicine ; 9, Heft 1 (25.5.2011), 1-9, 12.2011
- Urheber
-
Ciarapica, Roberta
- Beteiligte Personen und Organisationen
- DOI
-
10.1186/1741-7015-9-63
- URN
-
urn:nbn:de:1111-2016072225454
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ciarapica, Roberta
- Miele, Lucio
- Giordano, Antonio
- Locatelli, Franco
- Rota, Rossella
- SpringerLink (Online service)
Ähnliche Objekte (12)
High EZH2 expression is correlated to metastatic disease in pediatric soft tissue sarcomas
Targeting epigenetics in sarcomas through EZH2 inhibition
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Functional analysis and targeted inhibition of the enhancer of zeste homolog 2 (EZH2)-protein in human cancer cells
Pediatric bone and soft tissue sarcomas
Pediatric bone and soft-tissue sarcomas
Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
Emerging trends in immunotherapy for pediatric sarcomas
Notch signaling in pediatric soft tissue sarcomas
Targeting enhancer of zeste homolog 2 protects against acute kidney injury
Overexpression of Enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters
High EZH2 expression is correlated to metastatic disease in pediatric soft tissue sarcomas
Targeting epigenetics in sarcomas through EZH2 inhibition
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Functional analysis and targeted inhibition of the enhancer of zeste homolog 2 (EZH2)-protein in human cancer cells
Pediatric bone and soft tissue sarcomas
Pediatric bone and soft-tissue sarcomas
Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
Emerging trends in immunotherapy for pediatric sarcomas
Notch signaling in pediatric soft tissue sarcomas
Targeting enhancer of zeste homolog 2 protects against acute kidney injury
Overexpression of Enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters
High EZH2 expression is correlated to metastatic disease in pediatric soft tissue sarcomas
Targeting epigenetics in sarcomas through EZH2 inhibition
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Functional analysis and targeted inhibition of the enhancer of zeste homolog 2 (EZH2)-protein in human cancer cells
Pediatric bone and soft tissue sarcomas
Pediatric bone and soft-tissue sarcomas
Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
Emerging trends in immunotherapy for pediatric sarcomas
Notch signaling in pediatric soft tissue sarcomas
Targeting enhancer of zeste homolog 2 protects against acute kidney injury